This Support Group will be held at 10am Pacific Time/1pm Eastern.
Join us on Saturday, October 22, at 10:00 am PST. Make yourself comfortable at your computer, laptop, tablet, etc. and participate in what will be a very helpful and informative meeting.
The Life Raft Group is offering a virtual California Support Group with Southern California Leader Dina Wiley, PhD. The group will meet to talk to each other, discuss individual GIST issues, and get answers to questions. This will enable you to not only get some relief from the worry of GIST, but to also help others, as well. We are, after all, in the same life raft, and we are each needed to pull together. When we do, wonderful things happen!
And here’s the best part — we will have a very special guest – Dr. Adam Burgoyne, Moores Cancer Center, UCSD Health. He is currently involved with Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST) clinical trial. Dr. Burgoyne will be available to answer any questions you may have, and explain some of the mysteries of GIST.
About the Group Leader:
Dina Wiley – Dina is a long-time Southern California LRG Support Group Leader. Read about Dina’s GIST journey here
About Our Special Guest:
Adam Burgoyne, MD, PhD
Moores Cancer Center, UCSD Health
Dr. Burgoyne, is a board-certified medical oncologist who specializes in diagnosing and treating primary liver cancers such as hepatocellular carcinoma (HCC). He also treats cancers of the esophagus, gallbladder, pancreas, stomach, small intestine, colon and appendix, as well as gastrointestinal stromal tumors (GIST).
Dr. Burgoyne uses many forms of therapy, including traditional chemotherapy, immunotherapy and targeted therapy, with an emphasis on personalized medicine, to offer the best possible patient outcomes. Dr. Burgoyne is the medical oncologist for UC San Diego Health’s multidisciplinary liver cancer clinic. The clinic offers patients highly specialized and coordinated care at one convenient location, ensuring easy and timely access to the best cancer doctors and the most innovative treatment approaches.
As a physician-scientist, Dr. Burgoyne also leads original research to improve survival rates among people with primary liver cancer and other cancers affecting the digestive system. In particular, he is working on developing novel drugs that inhibit multiple targets within the cancer cell with a single agent. He also studies tumor genetics and the biology of gastrointestinal stromal tumors (GIST) to facilitate personalize cancer care. His work has appeared in Journal of Translational Medicine, Molecular Cancer Therapeutics, and Cancer, among others.
Dr. Burgoyne completed a fellowship in hematology and oncology at UC San Diego School of Medicine, where he was chief fellow. He also completed a residency in internal medicine at UC San Diego School of Medicine. Dr. Burgoyne earned his medical degree and doctorate from Case Western Reserve University School of Medicine in Cleveland, Ohio. He is board-certified in internal medicine and medical oncology.
Dr. Burgoyne is a member of the American Association for Cancer Research, the American Association for the Study of Liver Diseases, the American Society of Hematology, and the American Society of Clinical Oncology. He is a member of the Alpha Omega Alpha Honor Medical Society.